CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811489190
- Phone
- 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Slebir John L Chief Legal Officer | Grant or award · Stock Option (right to buy) | +1,199,482 | 1,199,482 | ||
| 2026-10-01 | Casale Donn President and CEO | Grant or award · Stock Option (right to buy) | +1,036,923 | 1,036,923 | ||
| 2026-09-01 | Smith Margaret Ekins Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +1,001,738 | 1,001,738 | ||
| 2026-07-01 | Casale Donn President | Grant or award · Stock Option (right to buy) | +898,456 | 898,456 | ||
| 2026-06-24 | Kelly Michael Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-24 | Shah Pratik Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-24 | Islam Saqib Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-24 | Shawver Laura Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-24 | Thompson Peter A. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-24 | SAUNDERS BRENT L Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-24 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2026-06-24 | SCHNEIDER PHILLIP M Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-24 | Dadoo Rajeev Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-12 | Karas Eric Chief Commercial Officer | Option exercise 10b5-1 | +25,000 | $1.50 | $38K | 37,176 |
| 2026-06-12 | Karas Eric Chief Commercial Officer | Sale 10b5-1 | −25,000 | $10.00 | $250K | 12,176 |
| 2026-06-12 | Karas Eric Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 519,588 | ||
| 2026-06-12 | Fitzpatrick Alexander A Chief Legal Officer | Sale 10b5-1 | −3,355 | $10.00 | $34K | 90,910 |
| 2026-01-02 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Grant or award · Stock option (right to buy) | +240,000 | 240,000 | ||
| 2026-01-02 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +875,000 | 875,000 | ||
| 2026-01-02 | Karas Eric Chief Commercial Officer | Grant or award · Stock option (right to buy) | +240,000 | 240,000 |
Page 1 of 14 · 267 trades